DUBLIN–(BUSINESS WIRE)–The “Global Peptide Synthesis Market by Reagent (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid & Recombinant), End-user (Pharma, Biotech, CRO), and Region – Forecast to 2026” report has been added to ResearchAndMarkets.com’s offering.
The global peptide synthesis market is projected to reach USD 730 million by 2026 USD 515 million in 2021, at a CAGR of 7.2% during the forecast period.
Growth in this market is driven by the increasing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and the development of advanced automated peptide synthesizers.
The reagents segment accounted for the highest growth rate in the peptide synthesis market, by product & service, during the forecast period
In 2020, the reagents segment accounted for the highest growth rate. The peptide synthesis reagents market is further segmented into resins, amino acids, coupling reagents, dyes and fluorescent labeling reagents, and other reagents (such as protecting reagents, linkers, buffers, solvents, and solutions).
The requirement of reagents in bulk quantities, especially in the most preferred solid-phase peptide synthesis method of peptide synthesis, is another factor responsible for the large share of this segment in the peptide synthesis market. GenScript Biotech Corporation (China), Thermo Fisher Scientific (US), AAPPTec (US), Bachem Holding AG (Switzerland), Kaneka Corporation (US), Biotage AB (Sweden), CEM Corporation (US), Mesa Laboratories, Inc. (Sweden), Advanced ChemTech (US), and Merck KGaA (Germany) are some of the major players operating in the peptide synthesis reagents market.
Asia Pacific: The fastest-growing region in the peptide synthesis market
The peptide synthesis market is segmented into North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA). The high growth in this market is attributed to growing R&D funding, rising research activity, and increasing investments by pharmaceutical and biotechnology companies in enhancing equipment and technology of production. The increasing applications of peptides in therapeutics is further expected to drive the peptide synthesis market in the Asia Pacific region.
Market Dynamics
Drivers
- Increasing Use of Peptides in Pharmaceutical Drugs
- Increase in Research Activities and the Availability of Funding for R&D
- Development of Advanced Automated Peptide Synthesizers
Restraints
- Lack of a Unified Set of Regulations for Therapeutic Peptides
- High Cost of Instruments
Opportunities
- Emerging Markets in the Asia-Pacific Region
- Development of Personalized Medicines
Challenges
- Issues Associated with the Route of Administration of Peptide Drugs
- Addressing the Environmental Impact of Chemical Synthesis of Peptides
Companies Mentioned
- AAPPtec
- Advanced Chemtech
- AmbioPharm Inc.
- AnyGen Co. Ltd.
- Aurigene Pharmaceutical Services Ltd.
- Bachem Holding AG
- Bio-Synthesis Inc.
- Biotage AB
- CEM Corporation
- ChemPep Inc.
- CordenPharma International
- CPC Scientific Inc.
- CSBio
- Dalton Pharma Services
- GenScript Biotech Corporation
- JPT Peptide Technologies GmbH
- Kaneka Corporation
- Luxembourg Bio Technologies Ltd.
- Merck KGaA
- Mesa Laboratories, Inc.
- ProteoGenix
- Purolite Pvt. Ltd.
- Syngene International Limited
- Thermo Fisher Scientific
- Vivitide
For more information about this report visit https://www.researchandmarkets.com/r/qgoo0
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900